selexipag

Poland

Drugs containing this active substance

  • SELEXIPAG POLPHARMA

    The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and relieves the symptoms of the disease.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 200 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which lowers the pressure within them, relieves disease symptoms, and slows its progression.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 400 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, relieves disease symptoms, and slows its progression.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 600 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which lowers the pressure within them, relieves disease symptoms, and slows its progression.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 800 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, relieves disease symptoms, and slows its progression.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 1000 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and may slow the progression of the disease.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 1200 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and relieves the symptoms of the disease.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 1400 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, and relieves the symptoms of the disease.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 1600 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients for whom other medicines have not produced the expected effects or who cannot use them.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 200 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It may be used alone or in combination with other medicines if the patient cannot take them.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 400 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients. It may be used alone or in combination with other medicines if the patient is not eligible for their use.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 600 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It helps to dilate the pulmonary arteries, which makes it easier for the heart to pump blood, lowers the pressure in these arteries, relieves disease symptoms, and slows its progression.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 800 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients for whom other medicines have not produced the expected effects or when other treatment methods cannot be used.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 1000 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It may be used alone or in combination with other medicines if the patient is not eligible for their use.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 1200 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • The medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients. It may be used alone or in combination with other medicines if previous treatments have not been effective.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 1400 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.

  • This medicine is used for the long-term treatment of pulmonary arterial hypertension (PAH) in adults. It may be used alone or in combination with other medicines.

    Form: tablets, film-coated

    Active substance Dosage
    selexipag 1600 mcg

    ATC: B01AC27

    Manufacturer: Synthon B.V. Synthon Hispania S.L. Synfon s.r.o.